C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2009
12/17/2009	US20090312247 Natriuretic peptide related fragment in cardiovascular disease
12/17/2009	US20090312190 Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses
12/17/2009	US20090311802 Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof
12/17/2009	US20090311799 Nucleic Acid Materials for Nonradiative Energy Transfer and Methods of Production and Use
12/17/2009	US20090311798 Se(r)rs displacement assay
12/17/2009	US20090311780 Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use
12/17/2009	US20090311779 Anti-p-selectin antibodies
12/17/2009	US20090311758 Process for preparing l-amino acids
12/17/2009	US20090311745 Group of esterases for the enantioselective production of fine and speciality chemicals
12/17/2009	US20090311743 Process for the Production, in Prokaryotes, of Active, Stable Transposases of Mariner Mobile Genetic Elements
12/17/2009	US20090311727 Recombinant deamidated gliadin antigen
12/17/2009	US20090311725 Polypeptide producing cells
12/17/2009	US20090311723 Fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening
12/17/2009	US20090311718 Degraded agonist antibody
12/17/2009	US20090311714 Methods for the Screening of Antibacterial Substances
12/17/2009	US20090311711 CRH and POMC Effects on Animal Growth
12/17/2009	US20090311704 Compositions and methods for diagnosis of autophagic vacuolar myopathy
12/17/2009	US20090311701 Organ-specific gene, method for identifying the same and use thereof
12/17/2009	US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
12/17/2009	US20090311695 Method
12/17/2009	US20090311694 Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases
12/17/2009	US20090311689 Genomic marker for tenderness meat
12/17/2009	US20090311688 Novel Labeled oligonucleotide
12/17/2009	US20090311687 Microorganisms detection and enumeration method
12/17/2009	US20090311683 Compositions for the use in identification of fungi
12/17/2009	US20090311679 TaqMan MGB probe useful for detecting the mitochondrial gene C1494T mutation associated with maternally inherited deafness and the use thereof
12/17/2009	US20090311677 Identification of contaminating bacteria in industrial ethanol fermentations
12/17/2009	US20090311676 Method for preparing primer used for determining the mutation in PDS gene related to large vestibular aqueduct syndrome in vitro and the use of the primer
12/17/2009	US20090311674 Phosphate Biosensors and Methods of Using the Same
12/17/2009	US20090311671 Diagnosis of risk of breast cancer
12/17/2009	US20090311665 Methods, compositions, and kits for collecting and detecting oligonucleotides
12/17/2009	US20090311398 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability
12/17/2009	US20090311287 Novel flavivirus antigens
12/17/2009	US20090311284 Recombinant Viral Proteins And Particles
12/17/2009	US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine
12/17/2009	US20090311278 Novel teleost derived antimicrobial polypeptides
12/17/2009	US20090311277 Nucleic acid compositions for stimulating immune responses
12/17/2009	US20090311274 Polynucleotide coding tumor protein for use as preventive, diagnostic and prognostic tool in treatment of cell proliferative disorders
12/17/2009	US20090311268 Cd40-binding activating antibodies
12/17/2009	US20090311265 Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof
12/17/2009	US20090311263 Human vascular ibp-like growth factor
12/17/2009	US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/17/2009	US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
12/17/2009	US20090311259 maytansinoid drug moieties covalently linked by a linker to an antibody which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors; cancer
12/17/2009	US20090311257 Human antibodies specific for gastrin materials and methods
12/17/2009	US20090311256 12 Human Secreted Proteins
12/17/2009	US20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof
12/17/2009	US20090311247 Molecules and chimeric molecules thereof
12/17/2009	US20090311229 Isolation and Identification of Cross-Reactive T Cells
12/17/2009	US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2
12/17/2009	US20090308324 Diabetes tests
12/17/2009	CA2765422A1 Single strand dimensional construction of dna in 3d space
12/17/2009	CA2726850A1 Method of synthesizing polynucleotide variants
12/17/2009	CA2724516A1 Novel nucleic acid transfer system
12/16/2009	EP2133430A2 Design and therapeutic use of adpase enhanced apyrases
12/16/2009	EP2133081A1 RNAi modulation of the BCR-ABL fusion gene and uses thereof
12/16/2009	EP2132984A2 Interferon-like protein ZCYTO21
12/16/2009	EP2132331A2 Method of diagnosing, classifying and treating endometrial cancer and precancer
12/16/2009	EP2132223A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
12/16/2009	EP1604020B1 Method to confer cell culture replication activity to different hepatitis c virus isolates
12/16/2009	EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines
12/16/2009	EP1042508B1 Methods for improved luminescence assays using microparticles
12/16/2009	EP0824541B1 Nucleic acid ligand complexes
12/16/2009	CN101605558A Influenza recombinant subunit vaccine
12/16/2009	CN100569945C Oligomeric compounds for the modulation of BCL-2
12/16/2009	CN100569799C Modified serum albumin with reduced affinity for nickel and copper
12/15/2009	US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
12/15/2009	US7632940 Process for the preparation of 4′-azido cytidine derivatives
12/15/2009	US7632939 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
12/15/2009	US7632938 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
12/15/2009	US7632937 electing a bait nucleic acid encoding a bait protein active in post transincriptional gene silencing or suppressive of PTGS in plants; preparing a cDNA prey library from a plant actively exhibits PTGS; conducting a yeast two-hybrid assay with the bait and prey nucleic acids, yields a true assay results
12/15/2009	US7632935 DNA encoding a mast cell-derived membrane protein
12/15/2009	US7632934 Oligonucleotides for amplifying Trichomonas vaginalis-derived nucleic acid
12/15/2009	US7632933 Corticotropin releasing factor 2 receptor agonists
12/15/2009	US7632932 a steroid or aromatic compound based ligand-conjugated difluorotolyl ribonucleoside; can be used to silence genes that are responsible for a particular disease ; stability
12/15/2009	US7632931 Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent
12/15/2009	US7632925 Antibodies that bind human 17-A1/EpCAM tumor antigen
12/15/2009	US7632920 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
12/15/2009	US7632824 Nucleobase sequence of a modified oligonucleotide complementary to a nucleic acid molecule encoding human Mcl-1, an antipoptoic protein of the Bcl-2 family; targeting and modulating expression of Mcl-1 in cells, tissue; antisense therapy, antitumor, -carcinogenic and -proliferative agents; autoimmune
12/15/2009	US7632823 Compositions of tRNA and uses thereof
12/15/2009	US7632822 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen
12/15/2009	US7632668 liquid solution comprising a thermotolerant phytase; Poultry and pig feed
12/15/2009	US7632667 Mutan endonuclease with substrate-specific cleavage activity
12/15/2009	US7632660 protein is encoded by nucleic acid molecules that interact or bind to B-aggressive lymphoma (BAL) molecules, which are differentially expressed in non-Hodgkin's lymphoma; diagnostic use; biodrug for treating B-cell lymphoma
12/15/2009	US7632659 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
12/15/2009	US7632642 Low temperature linear-after-the-exponential polymerase chain reactions; amplicons; fluorescent DNA dye; quantitative analysis
12/15/2009	US7632641 Hybridization chain reaction
12/15/2009	US7632640 Association of TSPYL polymorphisms with SIDDT syndrome
12/15/2009	US7632639 Hybridizing probe, ligating; microarrays; self-assembly
12/15/2009	US7632635 Method for measuring resistance of a patient HIV-2 to protease inhibitors
12/15/2009	US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009	US7632515 Streptococcus pneumoniae proteins and nucleic acid molecules
12/15/2009	US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009	US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders
12/15/2009	CA2347905C P53 antisense agent and method
12/15/2009	CA2330545C Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/15/2009	CA2132985C Nucleotide sequences which hybridize specifically with a campylobacter jejuni genomic nucleic sequence
12/13/2009	CA2643886A1 Selection of personalized cancer therapy regimens using interfering rna functional screening
12/10/2009	WO2009149253A2 Mrna cap analogs
12/10/2009	WO2009149189A2 Dual variable domain immunoglobulins and uses thereof

1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 899